Skip to main content

Table 1 Baseline Characteristics of the Study Participants in Wuhan, China (N = 84), 2021

From: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals

Characteristics

PLWH group

HNCs group

No. of participants

46

38

Age in years, median (IQR)

36 (31–42)

31 (27–39)

Men, No. (%)

40 (87)

19 (50)

Duration of infection, years

6 (3, 8)

–

Antiretroviral therapy, No. (%)

46 (100)

–

HIV-VL < 50 copies/mL, No. (%)

41 (89)

–

CD4 count (cells/µL), median

CD4 count < 200, No. (%)

CD4 count 200–349, No. (%)

CD4 count 350–499, No. (%)

CD4 count > 500, No. (%)

523 (351, 653)

2 (4)

8 (17)

11 (24)

25 (55)

675 (540, 828)

0 (0)

0 (0)

0 (0)

38 (100)

  1. Data are n (%), Standard Deviation (SD) or median (IQR). Data are for participants with HIV and without HIV included in this analysis